Critical Appraisal of the Milwaukee Protocol for Rabies: This Failed Approach Should Be Abandoned

Canadian Journal of Neurological Sciences

Volumn 43, Issue 1, 2015, Pages 44-51

  Zeiler, Frederick A ^a   Jackson, Alan C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

critical care; infections of the nervous system; infectious diseases; intensive care; Milwaukee protocol; neuroprotection; rabies; therapy; virology

Indexed keywords

AMANTADINE; ANESTHETIC AGENT; ARGININE; ASCORBIC ACID; GLUTAMIC ACID; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NIMODIPINE; RIBAVIRIN; SAPROPTERIN; SEDATIVE AGENT;

BRAIN VASOSPASM; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; EXCITOTOXICITY; HUMAN; INTENSIVE CARE; MAGNETIC RESONANCE ANGIOGRAPHY; MILWAUKEE PROTOCOL; MONITORING; NEUROPROTECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RABIES; REVIEW; SCREENING; SEDATION; THERAPEUTIC COMA; TRANSCRANIAL DOPPLER; TREATMENT FAILURE; VIRUS ENCEPHALITIS; COMPLICATION; ENCEPHALITIS, VIRAL; STANDARDS;

CLINICAL PROTOCOLS; ENCEPHALITIS, VIRAL; HUMANS; RABIES; TREATMENT FAILURE;

EID: 84955071341     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/cjn.2015.331     Document Type: Review

References (94)

1. Fooks AR, Banyard AC, Horton DL, Johnson N, McElhinney L, Jackson AC. Current status of rabies and prospects for elimination. Lancet. 2014;384:1389-99.
2. Jackson AC, Warrell MJ, Rupprecht CE, et al. Management of rabies in humans. Clin Infect Dis. 2003;36:60-3.
3. Jackson AC. Therapy of human rabies. In: Jackson AC, editor. Rabies: scientific basis of the disease and its management, Third Edition. Oxford, UK: Elsevier Academic Press, 2013: p. 573-87.
4. Willoughby RE, Jr., Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352:2508-14.
5. Hu WT, Willoughby RE, Jr., Dhonau H, Mack KJ. Long-term follow-up after treatment of rabies by induction of coma (Letter). N Engl J Med. 2007;357:945-6.
6. Willoughby RE, Jr. Milwaukee Protocol, version 4.0. 2012. Available from http://www.mcw.edu/FileLibrary/Groups/PedsInfectiousDiseases/Rabies/Milwaukee-protocol-v4-20913.pdf. Accessed on August 18, 2015.
7. Maier T, Schwarting A, Mauer D, et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis. 2010;50:1112-9.
8. Bagchi S. Coma therapy. The Telegraph. July 4, 2005. Calcutta.
9. Hemachudha T, Sunsaneewitayakul B, Desudchit T, et al. Failure of therapeutic coma and ketamine for therapy of human rabies. J Neurovirol. 2006;12:407-9.
10. Houston Chronicle Rabies, human - USA (Texas). ProMED-mail. 2006;20060513.1360: Available at http://www.promedmail.org/ Accessed August 18, 2015.
11. Christenson JC, Holm BM, Lechlitner S, et al. Human rabies - Indiana and California, 2006. MMWR. 2007;56:361-5.
12. Aramburo A, Willoughby RE, Bollen AW, et al. Failure of the Milwaukee Protocol in a child with rabies. Clin Infect Dis. 2011;53:572-4.
13. McDermid RC, Saxinger L, Lee B, et al. Human rabies encephalitis following bat exposure: failure of therapeutic coma. Can Med Assoc J. 2008;178:557-61.
14. Drosten C. Rabies - Germany (Hamburg) ex Morocco. ProMED-mail.2007;20070419.1287: April 19, 2007. Available at http://www.promedmail.org/ Accessed August 18, 2015.
15. van Thiel PP, de Bie RM, Eftimov F, et al. Fatal human rabies due to Duvenhage virus from a bat in Kenya: failure of treatment with coma-induction, ketamine, and antiviral drugs. PLoS Neglected Tropical Diseases. 2009;3:e428.
16. Rubin J, David D, Willoughby RE, Jr., et al. Applying the Milwaukee Protocol to treat canine rabies in Equatorial Guinea. Scand J Infect Dis. 2009;41:372-5.
17. Pue HL, Turabelidze G, Patrick S, et al. Human rabies - Missouri, 2008. MMWR. 2009;58:1207-9.
18. Turabelidze G, Pue H, Grim A, Patrick S. First human rabies case in Missouri in 50 years causes death in outdoorsman. Mo Med. 2009;106:417-9.
19. Caicedo Y, Paez A, Kuzmin I, et al. Virology, immunology and pathology of human rabies during treatment. Pediatr Infect Dis J. 2015;34:520-8.
20. Jackson AC, Garland A. Fatal rabies case did not die "accidentally" and should not be considered a rabies survivor (Letter). Pediatr Infect Dis J. 2015;34:677-8.
21. Badillo R, Mantilla JC, Pradilla G. Human rabies encephalitis by a vampire bat bite in an urban area of Colombia (Spanish). Biomédica. 2009;29:191-203.
22. Hunter M, Johnson N, Hedderwick S, et al. Immunovirological correlates in human rabies treated with therapeutic coma. J Med Virol. 2010;82:1255-65.
23. Blanton JD, Palmer D, Rupprecht CE. Rabies surveillance in the United States during 2009. J Am Vet Med Assoc. 2010;237:646-57.
24. Luminos M, Barboi G, Draganescu A, et al. Human rabies in a Romanian boy - an ante mortem case study. Rabies Bull Europe. 2011;35:5-10.
25. Santos A, Cale E, Dacheux L, Bourhy H, Gouveia J, Vasconcelos P. Fatal case of imported human rabies in Amadora, Portugal, August 2011. Eurosurveillance. 2012;17:20130.
26. Javaid W, Amzuta IG, Nat A, et al. Imported human rabies in a U.S. Army soldier - New York, 2011. MMWR Morb Mortal Wkly Rep. 2012;61:302-5.
27. Nat A, Nat A, Sharma A, Pothineni A, AmzutaI I. Looking beyond the Milwaukee Protocol (Abstract). Chest. 2014;145:117A.
28. Greer DM, Robbins GK, Lijewski V, Gonzalez RG, McGuone D. Case records of the Massachusetts General Hospital: Case 1-2013: a 63-year-old man with paresthesias and difficulty swallowing. N Engl J Med. 2013;368:172-80.
29. NE 10 Rabies, human - Brazil (03): (Ceara). ProMED-mail..2012;20120314.1070531: March 14, 2012. Available at http://www.promedmail.org/ Accessed August 18, 2015.
30. Branswell H. Testing suggests Toronto rabies case infected in Dominican Republic. The Globe and Mail. April 19, 2012. Toronto.
31. Times Live Rabies - South Africa (02): (Kwazulu-Natal), human ex Mozambique. ProMED-mail.2012;20120528.1147931: May 28, 2012. Available at http://www.promedmail.org/ Accessed August 18, 2015.
32. IAfrica.com Rabies - South Africa (03): (Kwazulu-Natal), human ex Mozambique. ProMED-mail.2012;20120608.1160328: June 8, 2012. Available at http://www.promedmail.org/ Accessed August 18, 2015.
33. Pathak S, Horton DL, Lucas S, et al. Diagnosis, management and post-mortem findings of a human case of rabies imported into the United Kingdom from India: a case report. Virol J. 2014;11:63.
34. Wallace RM, Bhavnani D, Russell J, et al. Rabies death attributed to exposure in Central America with symptom onset in a U.S. detention facility - Texas, 2013. MMWR Morb Mortal Wkly Rep. 2014;63:446-9.
35. Chen YG, Kan LP, Lee CH, et al. Symptomatic hypercalcemia in a rabies survivor underwent hemodialysis. Hemodial Int. 2015;19:347-51.
36. Ramya M. Madras Christian College student, a dog lover, dies of rabies. The Times of India. February 22, 2014. Chennai.
37. Elsiesy H, Hussain I, Abaalkhail FA, et al. Rabies outbreak involving four transplant recipients in Kuwait and Saudi Arabia. Presentation at the XXVIth International Meeting on Research Advances and Rabies Control in the Americas in Fort Collins, Colorado, USA on October 5, 2015.
38. Al Mousawi MSA. Transmission of rabies virus from a deceased organ donor to six recipients in Kuwait and Saudi Arabia. Presented at the 2015 Organ Donation Congress in Seoul, South Korea on October 18, 2015.
39. Wiedeman J, Plant J, Glaser C, et al. Recovery of a patient from clinical rabies - California, 2011. MMWR. 2012;61:61-5.
40. Ministerio da Saude in Brazil Rabies, human survival, bat - Brazil: (Pernambuco). ProMED-mail.2008;20081114.3599: Available at http://www.promedmail.org/ Accessed August 18, 2015.
41. Holzmann-Pazgal G, Wanger A, Degaffe G, et al. Presumptive abortive human rabies - Texas, 2009. MMWR. 2010;59:185-90.
42. Palmer A, McVey E, McNeill KM, et al. Human rabies - Mississippi, 2005. MMWR. 2006;55:207-8.
43. Blanton JD, Hanlon CA, Rupprecht CE. Rabies surveillance in the United States during 2006. J Am Vet Med Assoc. 2007;231: 540-56.
44. Yee AH, Merrell RT, Zubkov AY, et al. Human rabies - Minnesota, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:460-2.
45. Fukagawa C, Alvarez F, Messenger S, et al. Imported human rabies-California, 2008. MMWR Morb Mortal Wkly Rep. 2009;58:713-6.
46. House J, Poe J, Humbaugh K, et al. Human rabies - Kentucky/Indiana, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:393-6.
47. Signs K, Stobierski MG, Rupprecht CE, Robertson K. Human rabies - Michigan, 2009. MMWR Morb Mortal Wkly Rep. 2011;60:437-40.
48. Troell P, Miller-Zuber B, Ondrush J, et al. Human rabies - Virginia, 2009. MMWR. 2010;59:1236-8.
49. Balsamo G, Ratard RC, Thoppil DR, et al. Human rabies from exposure to a vampire bat in Mexico - Louisiana, 2010. MMWR Morb Mortal Wkly Rep. 2011;60:1050-2.
50. Kazmierczak JJ, Davis JP, Brauer E, Recuenco S, Rupprecht CE, Bartholomew M. Human rabies - Wisconsin, 2010. MMWR Morb Mortal Wkly Rep. 2011;60:1164-6.
51. Prasek D, Mamon R, Stepanyuk O, et al. Imported human rabies - New Jersey, 2011. MMWR Morb Mortal Wkly Rep. 2012; 60:1734-6.
52. Vora NM, Basavaraju SV, Feldman KA, et al. Raccoon rabies virus variant transmission through solid organ transplantation. JAMA. 2013;310:398-407.
53. Blanton JD, Dyer J, McBrayer J, Rupprecht CE. Rabies surveillance in the United States during 2011. J Am Vet Med Assoc. 2012;241:712-22.
54. Rupprecht CE, Brenner E, Cox S, et al. Human rabies - South Carolina, 2011. MMWR Morb Mortal Wkly Rep. 2013;62:642-4.
55. Farley S, Zarate S, Jenssen E, et al. U.S-acquired human rabies with symptom onset and diagnosis abroad, 2012. MMWR Morb Mortal Wkly Rep. 2012;61:777-81.
56. Reinke SN, Resch L, Maingut F, et al. Metagenomic and metabolomic characterization of rabies encephalitis: new insights into the treatment of an ancient disease. J Inf Dis. 2013;207:1451-6.
57. Solomon T, Marston D, Mallewa M, et al. Paralytic rabies after a two week holiday in India. BMJ. 2005;331:501-3.
58. Johnson N, Brookes SM, Fooks AR, Ross RS. Review of human rabies cases in the UK and in Germany. Vet Rec. 2005;157:715.
59. Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010;460:525-42.
60. Di X, Bullock R, Watson J, et al. Effect of CP101,606, a novel NR2B subunit antagonist of the N-methyl-D-aspartate receptor, on the volume of ischemic brain damage off cytotoxic brain edema after middle cerebral artery occlusion in the feline brain. Stroke. 1997;28:2244-51.
61. Morris GF, Bullock R, Marshall SB, Marmarou A, Maas A, Marshall LF. Failure of the competitive N-methyl-D-aspartate antagonist Self-otel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators. J Neurosurg. 1999;91:737-43.
62. Hoyte L, Barber PA, Buchan AM, Hill MD. The rise and fall of NMDA antagonists for ischemic stroke. Curr Mol Med. 2004;4:131-6.
63. Giacino JT, Whyte J, Bagiella E, et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med. 2012;366:819-26.
64. Nargi-Aizenman JL, Havert MB, Zhang M, Irani DN, Rothstein JD, Griffin DE. Glutamate receptor antagonists protect from virus-induced neural degeneration. Ann Neurol. 2004;55:541-9.
65. Mori I, Liu B, Hossain MJ, et al. Successful protection by amantadine hydrochloride against lethal encephalitis caused by a highly neurovirulent recombinant influenza A virus in mice. Virology. 2002;303:287-96.
66. Robertson WC Jr., Clark DB, Markesbery WR. Review of 38 cases of subacute sclerosing panencephalitis: effect of amantadine on the natural course of the disease. Ann Neurol. 1980;8:422-5.
67. Darman J, Backovic S, Dike S, et al. Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. J Neurosci. 2004;24:7566-75.
68. Nargi-Aizenman JL, Griffin DE. Sindbis virus-induced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor antagonists. J Virol. 2001;75:7114-21.
69. Kaul M, Lipton SA. Neuroinflammation and excitotoxicity in neurobiology of HIV-1 infection and AIDS: targets for neuroprotection. In: Malva JO, Rego AC, Cunha RA, Oliveira CR, editors. Interaction between neurons and glia in aging and disease. New York: Springer Science, 2007: p. 281-308.
70. Weli SC, Scott CA, Ward CA, Jackson AC. Rabies virus infection of primary neuronal cultures and adult mice: failure to demonstrate evidence of excitotoxicity. J Virol. 2006;80:10270-3.
71. Glezer I, Zekki H, Scavone C, Rivest S. Modulation of the innate immune response by NMDA receptors has neuropathological consequences. J Neurosci. 2003;23:11094-103.
72. Appolinario CM, Jackson AC. Antiviral therapy for human rabies. Antivir Ther. 2015;22:1-10.
73. Lockhart BP, Tordo N, Tsiang H. Inhibition of rabies virus transcription in rat cortical neurons with the dissociative anesthetic ketamine. Antimicrob Agents Chemother. 1992;36:1750-5.
74. Schifilliti D, Grasso G, Conti A, Fodale V. Anaesthetic-related neuroprotection: intravenous or inhalational agents? Cns Drugs. 2010; 24:893-907.
75. Roberts I, Sydenham E. Barbiturates for acute traumatic brain injury. Cochrane Database Syst Rev. 2012;12:CD000033.
76. Kramer AH. Viral encephalitis in the ICU. Crit Care Clin. 2013;29:621-49.
77. Shehabi Y, Chan L, Kadiman S, et al. Sedation depth and long-term mortality in mechanically ventilated critically ill adults: a prospective longitudinal multicentre cohort study. Intensive Care Med. 2013;39:910-8.
78. Wieske L, Chan Pin Yin DR, Verhamme C, Schultz MJ, van Schaik IN, Horn J. Autonomic dysfunction in ICU-acquired weakness: a prospective observational pilot study. Intensive Care Med. 2013; 39:1610-7.
79. Schmidt H, Hoyer D, Wilhelm J, et al. The alteration of autonomic function in multiple organ dysfunction syndrome. Crit Care Clin. 2008;24:149-63; ix.
80. Willoughby RE, Roy-Burman A, Martin KW, et al. Generalised cranial artery spasm in human rabies. In: Dodet B, Fooks AR, Müller T, Tordo N, editors. Towards the elimination of rabies in Eurasia. Basel: Kager, 2008: p. 367-75.
81. Sing TM, Soo MY. Imaging findings in rabies. Australas Radiol. 1996;40:338-41.
82. Budohoski KP, Guilfoyle M, Helmy A, et al. The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2014; 85:1343-53.
83. Willoughby RE, Opladen T, Maier T, et al. Tetrahydrobiopterin deficiency in human rabies. J Inherit Metab Dis. 2009;32:65-72.
84. Marshall SA, Nyquist P, Ziai WC. The role of transcranial Doppler ultrasonography in the diagnosis and management of vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am. 2010;21:291-303.
85. Rigamonti A, Ackery A, Baker AJ. Transcranial Doppler monitoring in subarachnoid hemorrhage: a critical tool in critical care. Can J Anaesth. 2008;55:112-23.
86. Hanggi D. Monitoring and detection of vasospasm II: EEG and invasive monitoring. Neurocrit Care. 2011;15:318-23.
87. Dorhout Mees SM, Rinkel GJ, Feigin VL, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007:CD000277.
88. Langham J, Goldfrad C, Teasdale G, Shaw D, Rowan K. Calcium channel blockers for acute traumatic brain injury. Cochrane Database Syst Rev. 2003:CD000565.
89. Kawakami M, Kodama N, Toda N. Suppression of the cerebral vasospastic actions of oxyhemoglobin by ascorbic acid. Neurosurgery. 1991;28:33-9.
90. Banic S. Prevention of rabies by vitamin c. Nature. 1975;258:153-4.
91. Perko D, Pretnar-Oblak J, Sabovic M, Zvan B, Zaletel M. Differences between cerebrovascular reactivity to L-arginine in the anterior and posterior cerebral circulation. Cerebrovasc Dis. 2011;31:358-64.
92. Diringer MN, Bleck TP, Claude HJ III, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15:211-40.
93. Velat GJ, Kimball MM, Mocco JD, Hoh BL. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature. World Neurosurg. 2011;76:446-54.
94. Jackson AC. Current and future approaches to the therapy of human rabies. Antiviral Res. 2013;99:61-7.